BOA1

Featured post

#Avian #Influenza #H7N9 in #China: Preventing the Next #SARS (@WHO, Apr. 2 ‘17)

  Title : #Avian #Influenza #H7N9 in #China: Preventing the Next #SARS. Subject : Avian Influenza, H7N9 subtype (Asian Lineage), poultry e...

9 May 2017

#Zika Virus – #Journals #Archives, recently added articles (May 9 2017)

 

Title: #Zika Virus – #Journals #Archives, recently added articles (May 9 2017).

Subject: Zika Virus and related complications, deep web scan for Journals’ Archives.

Source: WorldWideScience.org, full page: (LINK).

Code: [  R  ]

____

See more at –> WorldWideScience.org - Alerts for 2017-05-09

____

New entries:

___

      • Frankel MB; Pandya K; Gersch J; Siddiqui S; Schneider GJ.
      • 2017-05-01  Journal of virological methods
      • DOI: 10.1016/j.jviromet.2017.05.002  ISSN: 0166-0934  PMID: 28479349
        • Zika virus is an arthropod-borne flavivirus that has rapidly developed into a world-wide concern. Discovered in 1947, the virus was relatively obscure until an outbreak occurred in 2007 in the Yap islands and spread eventually to the Americas in 2015. Only 20% of patients infected with Zika virus develop symptoms. However, there can be serious consequences of infection including birth defects in developing fetuses and links to Guillain-Barré syndrome. The swift rise in infections has necessitated the development of diagnostic tests for both the detection of viral RNA and the presence of virus-specific antibodies. Abbott has developed a dual target RT-PCR assay for the detection of Zika virus RNA within serum, plasma, whole blood, and urine using the automated m2000 system for sample extraction to result reporting. The Abbott RealTime ZIKA assay has a limit of detection of 30 copies per mL in serum, 40 copies per mL in plasma and urine, and 120 copies per mL in whole blood and demonstrates high specificity against challenges from closely related infectious agents.
      • Salinas JL; Major CG; Pastula DM; Dirlikov E; Styczynski A; Luciano CA; Wojna V; Sharp TM; Sejvar JJ; Rivera-Garcia B.
      • 2017-06-01  Journal of the neurological sciences
      • DOI: 10.1016/j.jns.2017.04.006  ISSN: 0022-510X  Volume: 377  Pages: 102-106  PMID: 28477675
        • Zika virus has been associated with increases in Guillain-Barré syndrome (GBS) incidence. A GBS incidence estimation and clinical description was performed to assess baseline GBS epidemiology before the introduction of Zika virus in Puerto Rico.Hospitalization administrative data from an island-wide insurance claims database and U.S. Census Bureau population estimates provided a crude GBS incidence for 2013. This estimate was adjusted using the proportion of GBS cases meeting Brighton criteria for confirmed GBS from nine reference hospitals. Characteristics of confirmed GBS cases in the same nine hospitals during 2012-2015 are described.A total of 136 GBS hospitalization claims were filed in 2013 (crude GBS incidence was 3.8 per 100,000 population). The adjusted GBS incidence was 1.7 per 100,000 population. Of 67 confirmed GBS cases during 2012-2015, 66% had an antecedent illness. Median time from antecedent illness to GBS onset was 7days. Most cases (67%) occurred during July-September.Puerto Rico's GBS incidence for 2013 was estimated using a combination of administrative data and medical records review; this method could be employed in other regions to monitor GBS incidence before and after the introduction of GBS infectious triggers.

___

Copyright © 2017 Deep Web Technologies, Inc. All Rights Reserved

-

Keywords: Zika Virus; WWS; Research; Abstracts.

------